Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Anypodetos
m (Simplify markup, replaced:  • →  • (35) using AWB)
blackwiki>Anypodetos
m (Ticagrelor marketed)
Line 9: Line 9:
  
 
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
 
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
|  list1 = [[Abciximab]] • [[Eptifibatide]] • [[Tirofiban]]
+
|  list1 = [[Abciximab]] • [[Eptifibatide]] • [[Tirofiban]]
  
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] inhibitors
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] inhibitors
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]], [[Prasugrel]], [[Ticlopidine]])&nbsp;• [[Ticagrelor]]<sup>†</sup>
+
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]], [[Prasugrel]], [[Ticlopidine]])&nbsp;• [[Ticagrelor]]
  
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
|  list3 = [[Beraprost]]&nbsp;• [[Prostacyclin]]&nbsp;• [[Iloprost]]&nbsp;• [[Treprostinil]]
+
|  list3 = [[Beraprost]]&nbsp;• [[Prostacyclin]]&nbsp;• [[Iloprost]]&nbsp;• [[Treprostinil]]
  
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>&nbsp;• [[Aloxiprin]]&nbsp;• [[Carbasalate calcium]]&nbsp;• [[Indobufen]]&nbsp;• [[Triflusal]]
+
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>&nbsp;• [[Aloxiprin]]&nbsp;• [[Carbasalate calcium]]&nbsp;• [[Indobufen]]&nbsp;• [[Triflusal]]
  
 
| group5 = [[Thromboxane]] inhibitors
 
| group5 = [[Thromboxane]] inhibitors
|  list5 = ''[[thromboxane synthase]] inhibitors'' ([[Dipyridamole]], [[Picotamide]])&nbsp;• ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
+
|  list5 = ''[[thromboxane synthase]] inhibitors'' ([[Dipyridamole]], [[Picotamide]])&nbsp;• ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
  
 
| group6 = [[Phosphodiesterase inhibitor]]s
 
| group6 = [[Phosphodiesterase inhibitor]]s
|  list6 = [[Cilostazol]]&nbsp;• [[Dipyridamole]]&nbsp;• [[Triflusal]]
+
|  list6 = [[Cilostazol]]&nbsp;• [[Dipyridamole]]&nbsp;• [[Triflusal]]
  
 
| group7 = Other  
 
| group7 = Other  
|  list7 = [[Cloricromen]]&nbsp;• [[Ditazole]]
+
|  list7 = [[Cloricromen]]&nbsp;• [[Ditazole]]
  
 
}}
 
}}
Line 36: Line 36:
  
 
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
 
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]&nbsp;• [[Coumatetralyl]]&nbsp;• [[Dicoumarol]]&nbsp;• [[Ethyl biscoumacetate]]&nbsp;• [[Phenprocoumon]]&nbsp;• [[Warfarin]]
+
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]&nbsp;• [[Coumatetralyl]]&nbsp;• [[Dicoumarol]]&nbsp;• [[Ethyl biscoumacetate]]&nbsp;• [[Phenprocoumon]]&nbsp;• [[Warfarin]]
  
''[[1,3-Indandione]]s:'' [[Clorindione]]&nbsp;• [[Diphenadione]]&nbsp;• [[Phenindione]]
+
''[[1,3-Indandione]]s:'' [[Clorindione]]&nbsp;• [[Diphenadione]]&nbsp;• [[Phenindione]]
  
 
''other:'' [[Tioclomarol]]  
 
''other:'' [[Tioclomarol]]  
Line 61: Line 61:
 
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<br />
 
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<br />
  
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]&nbsp;• [[Dabigatran]]&nbsp;• [[Melagatran]]<sup>‡</sup>&nbsp;• [[Ximelagatran]]<sup>‡</sup>
+
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]&nbsp;• [[Dabigatran]]&nbsp;• [[Melagatran]]<sup>‡</sup>&nbsp;• [[Ximelagatran]]<sup>‡</sup>
  
 
| group8 = Other  
 
| group8 = Other  
|  list8 = [[REG1<!--instantly reversible aptamer based direct FIXa inhibitor in IIb trials -->]]&nbsp;• [[Defibrotide]]&nbsp;• [[Ramatroban]]&nbsp;• [[Antithrombin|Antithrombin III]]&nbsp;• [[Protein C]] ([[Drotrecogin alfa]])
+
|  list8 = [[REG1<!--instantly reversible aptamer based direct FIXa inhibitor in IIb trials -->]]&nbsp;• [[Defibrotide]]&nbsp;• [[Ramatroban]]&nbsp;• [[Antithrombin|Antithrombin III]]&nbsp;• [[Protein C]] ([[Drotrecogin alfa]])
  
 
}}
 
}}
  
 
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
 
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
|  list5 = ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]])&nbsp;• ''UPA'' ([[Urokinase]], [[Saruplase]])&nbsp;• [[Streptokinase]]<sup>#</sup>&nbsp;• [[Anistreplase]]&nbsp;• [[Monteplase]]
+
|  list5 = ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]])&nbsp;• ''UPA'' ([[Urokinase]], [[Saruplase]])&nbsp;• [[Streptokinase]]<sup>#</sup>&nbsp;• [[Anistreplase]]&nbsp;• [[Monteplase]]
  
''other [[serine endopeptidase]]s:'' [[Ancrod]]&nbsp;• [[Fibrinolysin]]
+
''other [[serine endopeptidase]]s:'' [[Ancrod]]&nbsp;• [[Fibrinolysin]]
  
 
[[Brinase]]
 
[[Brinase]]
Line 77: Line 77:
  
 
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
 
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
|  list8 = [[Citrate]]&nbsp;• [[EDTA]]&nbsp;• [[Oxalate]]
+
|  list8 = [[Citrate]]&nbsp;• [[EDTA]]&nbsp;• [[Oxalate]]
  
 
| group9 =  
 
| group9 =  

Revision as of 16:58, 2 February 2011